Why baby boomers are going from buyers to sellers
The ageing population may be good for annuities businesses but for everyone else the demographics spell bad news for returns.
Last updated: Updating...
Indices | Value | Change | %Change |
---|---|---|---|
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% |
Indices | Value | Change | %Change |
---|---|---|---|
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% |
commodities | Value | Change | %Change |
---|---|---|---|
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% |
commodities | Value | Change | %Change |
---|---|---|---|
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% | |
0.0000 | 0.0000 | 0.000% |
Company Code | Company | Price | %Change |
---|
Company Code | Company | Price | %Change |
---|
Last updated: Updating...
The ageing population may be good for annuities businesses but for everyone else the demographics spell bad news for returns.
Fund managers with billions to invest are distorting valuations of small caps. Heaven help shareholders when they decide to sell.
Perhaps they were misled, but dairy farmers who were expecting to pocket the upside can't expect taxpayers to subsidise their downside.
ASX-hopeful Perpetual Guardian has asked five investment banks to pitch potential deal structures and valuations for its mooted $150 million initial public offering.
An early positive lead from record-breaking Wall Street gave way to local concerns as investor appetite waned in the banks.
How do you provide enough monetary stimulus to keep households spending, without sparking a huge surge in the price of the family home?
A new economic reality calls for a new approach to central banking.
About 84 per cent of stocks on the ASX 200 are trading above their 200-day moving averages. What signal is this sending about the market's d...
AMP Capital has said shareholders in its shuttered China Growth Fund will get their first tranche of capital back by the end of September.
ValueAct has previously invested in Microsoft, American Express, Adobe Systems and struggling drug maker Valeant.
Unlimited access to business news and market insights across any device
Already a subscriber? Log in